Among the companies with shares expected to actively trade in
Monday's session are Coventry Health Care Inc. (CVH) and Corinthian
Colleges Inc. (COCO).
Aetna Inc. (AET) plans to buy Coventry Health Care Inc. (CVH)
for $5.7 billion in cash and stock, a move that will make Aetna one
of the largest providers of government-financed health care.
Coventry shares jumped 17% to $40.95 premarket; Aetna is offering
$42.08 a share. Known more for commercial health insurance, Aetna
has been interested in expanding government-based health
plans--Medicare for the elderly and Medicaid for the poor--that are
growing as baby boomers and states look for help managing Medicaid
costs.
Corinthian Colleges Inc. (COCO) swung to a loss in its fiscal
fourth quarter, hurt by discontinued operations. The company also
pointed to looming challenges for fiscal 2013, including the loss
of federal funding for students who lack a high school diploma or
GED. Shares slumped 6.1% to $2.30.
Lowe's Cos.'s (LOW) fiscal second-quarter earnings fell 10% as
the home-improvement retailer saw its margins squeezed and
same-store sales slip. Shares were down 6.1% at $26.16.
Mobile-device accessory maker ZAGG Inc. (ZAGG) said its
co-founder, Robert G. Pedersen II, resigned as chief executive and
chairman. Shares fell 6.2% to $7.90 premarket.
Watchlist:
ATP Oil & Gas Corp. (ATPG) filed for Chapter 11 bankruptcy
protection Friday, hit by the rising costs associated with its
deepwater drilling projects in the Gulf of Mexico.
Women's clothing retailer bebe Stores Inc. (BEBE) said its
president, Emilia Fabricant, resigned for personal reasons,
effective Friday.
Carmike Cinemas Inc. (CKEC) said it received a "nonspecific on
Thursday.
Energy Transfer Partners LP (ETP) filed plans to offer up to $1
billion in common units and debt securities, as the pipeline
operator looks to raise funds for general partnership purposes.
Meta Financial Group Inc. (CASH) unveiled plans to sell about
$34.2 million in stock at a 6.8% discount to Friday's closing
price, as the company looks to further capitalize its MetaBank
unit.
Pharmacyclics Inc. (PCYC) said the enrollment of a fifth patient
in a clinical trial for a non-Hodgkins lymphoma treatment has
triggered another $50 million milestone payment from Janssen
Biotech Inc., a unit of Johnson & Johnson (JNJ).
Write to Mia Lamar at mia.lamar@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires